SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR+3.9%
5Y CAGR-19.1%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+3.9%/yr
Annual compound
5Y CAGR
-19.1%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthDecelerating
PeriodValue
202514.26%
202413.00%
2023158.94%
202212.73%
2021-22.88%
202041.22%
201923.31%
2018-68.93%
201753.44%
20160.00%